Tempest Therapeutics Announces Up to $7.5 Million Private Placement
Tempest Therapeutics entered into definitive agreements for a private placement of 3,105,591 shares (or pre-funded warrants) at a combined price of $0.805 per share, with series C and series D warrants attached, expected to close on or about September 14, 2026. Upfront gross proceeds are expected to be roughly $2.5 million, with up to $5 million more if the warrants — covering 3,105,591 shares each at a $0.805 exercise price, exercisable only after stockholder approval — are fully exercised; no assurance of exercise is given. H.C.
Key figures
- Deal Value Usd
- 2500000
- Offering Price
- 0.805
- Shares Offered
- 3105591
- Expected close
- September 14, 2026
- Warrant coverage
- 200%
- Series c warrant term
- 6 years from later of Stockholder Approval Date and Effectiveness Date
- Series d warrant term
- 3 years from later of Stockholder Approval Date and Effectiveness Date
- Upfront gross proceeds
- 2500000
- Warrant exercise price
- 0.805
- Series c warrant shares
- 3105591
- Series d warrant shares
- 3105591
- Potential warrant proceeds
- 5000000
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.